OnTrackCF: Engagement, Feasibility, and Acceptability Study

Recruiting N/A Interventional Study
Cystic Fibrosis (CF) Cystic Fibrosis - Complete
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
60 (estimated)
Sponsor
Boston Children's Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This is a multi-site, nonrandomized study using mixed methods approach to evaluate the feasibility, acceptability, and user engagement of OnTrackCF for adults with Cystic Fibrosis (AWCF).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Diagnosed with CF 2. 18+ years of age 3. Prescribed a CFTR modulator therapy to be taken twice a day 4. Can speak and read English 5. Have regular access to an iOS or Android tablet or smartphone with internet access. Exclusion Criteria: 1\) Any situation, in the opinion of…
Contacts

Emma M McWilliams, BA

617-355-7534

emma.mcwilliams@childrens.harvard.edu

CONTACT

Callie Bacon, MPH

617-919-7696

callie.bacon@childrens.harvard.edu

CONTACT